000 | 01984 a2200565 4500 | ||
---|---|---|---|
005 | 20250517120532.0 | ||
264 | 0 | _c20170818 | |
008 | 201708s 0 0 eng d | ||
022 | _a1097-6825 | ||
024 | 7 |
_a10.1016/j.jaci.2016.08.033 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGabrion, Aurélie | |
245 | 0 | 0 |
_aMammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease. _h[electronic resource] |
260 |
_bThe Journal of allergy and clinical immunology _cMay 2017 |
||
300 |
_a1641-1649.e6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCytokines _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGranulomatous Disease, Chronic _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aInflammation _ximmunology |
650 | 0 | 4 |
_aInterleukin 1 Receptor Antagonist Protein _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMonocytes _xdrug effects |
650 | 0 | 4 |
_aPhagocytes _xdrug effects |
650 | 0 | 4 |
_aSirolimus _xpharmacology |
650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aHmitou, Isabelle | |
700 | 1 | _aMoshous, Despina | |
700 | 1 | _aNeven, Bénédicte | |
700 | 1 | _aLefèvre-Utile, Alain | |
700 | 1 | _aDiana, Jean-Sébastien | |
700 | 1 | _aSuarez, Félipe | |
700 | 1 | _aPicard, Capucine | |
700 | 1 | _aBlanche, Stéphane | |
700 | 1 | _aFischer, Alain | |
700 | 1 | _aCavazzana, Marina | |
700 | 1 | _aTouzot, Fabien | |
773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 139 _gno. 5 _gp. 1641-1649.e6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaci.2016.08.033 _zAvailable from publisher's website |
999 |
_c26483374 _d26483374 |